Molecular classification, treatment, and genetic biomarkers in triple-negative breast cancer: a review
B Lu, E Natarajan… - … in Cancer Research …, 2023 - journals.sagepub.com
Breast cancer is the most common malignancy and the second most common cause of
cancer-related mortality in women. Triple-negative breast cancers do not express estrogen …
cancer-related mortality in women. Triple-negative breast cancers do not express estrogen …
Molecular targets and therapeutic strategies for triple-negative breast cancer
Y Bhat, MR Thrishna, S Banerjee - Molecular Biology Reports, 2023 - Springer
Triple-negative breast cancer (TNBC) is known for its heterogeneous complexity and is often
difficult to treat. TNBC lacks the expression of major hormonal receptors like estrogen …
difficult to treat. TNBC lacks the expression of major hormonal receptors like estrogen …
[HTML][HTML] Prevalence and mortality of triple-negative breast cancer in West Africa: Biologic and sociocultural factors
Africa is the second-largest continent by population. 1 With 54 countries across five
geographical regions (Northern, Western, Middle, Eastern, and Southern Africa), the …
geographical regions (Northern, Western, Middle, Eastern, and Southern Africa), the …
[HTML][HTML] Latest Therapeutical Approaches for Triple-Negative Breast Cancer: From Preclinical to Clinical Research
Triple-negative breast cancer (TNBC) represents roughly one-sixth of all breast cancer
patients, but accounts for 30–40% of breast cancer deaths. Due to the lack of typical …
patients, but accounts for 30–40% of breast cancer deaths. Due to the lack of typical …
Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer
P Qiu, Q Guo, Q Yao, J Chen, J Lin - PLoS One, 2021 - journals.plos.org
Breast cancer (BC) is the most common malignancy in female, but the role of androgen
receptor (AR) in triple-negative breast cancer (TNBC) is still unclear. This study aimed to …
receptor (AR) in triple-negative breast cancer (TNBC) is still unclear. This study aimed to …
Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features
S Vtorushin, A Dulesova, N Krakhmal - Journal of Zhejiang University …, 2022 - Springer
According to the classification presented by Lehmann BD (2016), triple-negative breast
cancer (TNBC) is a heterogeneous group of malignant tumors with four specific subtypes …
cancer (TNBC) is a heterogeneous group of malignant tumors with four specific subtypes …
Lipidomic and membrane mechanical signatures in triple-negative breast cancer: scope for membrane-based theranostics
R Dadhich, S Kapoor - Molecular and Cellular Biochemistry, 2022 - Springer
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer
associated with poor prognosis, higher grade, and a high rate of metastatic occurrence …
associated with poor prognosis, higher grade, and a high rate of metastatic occurrence …
Potential epigenetic modifications implicated in triple-to quadruple-negative breast cancer transition: a review
Current research on triple-negative breast cancer (TNBC) has resulted in delineation into
the quadruple-negative breast cancer (QNBC) subgroup. Epigenetic modifications such as …
the quadruple-negative breast cancer (QNBC) subgroup. Epigenetic modifications such as …
Are transcription factors plausible oncotargets for triple negative breast cancers?
Simple Summary Triple negative breast cancer is a type of breast cancer that does not have
a selective and effective therapy. It is known that this cancer possesses high abundance of …
a selective and effective therapy. It is known that this cancer possesses high abundance of …
Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes
S Park, J Choi, JK Song, B Jang, YH Maeng - Medical Molecular …, 2024 - Springer
Abstract Chromobox (CBX) 2 and CBX7, members of CBX family protein, show diverse
expression patterns and contrasting roles in certain cancers. We aimed to investigate the …
expression patterns and contrasting roles in certain cancers. We aimed to investigate the …